Connectomic Deep Brain Stimulation for Obsessive Compulsive Disorder
NCT: NCT05160129 · RECRUITING
Brief Summary
Deep brain stimulation (DBS) is an effective treatment for people suffering from severe obsessive-compulsive disorder (OCD) whose symptoms have failed to improve after years and multiple methods of intervention. An effective DBS target for OCD is the anterior limb of the internal capsule (ALIC) brain region. On average 60% of all OCD patients have a clinically significant response to ALIC DBS. However, ALIC DBS may become even more effective with the ability to predict which specific ALIC connections in the brain need to be stimulated for each individual OCD patient. This study therefore investigates personalized stimulation to the ALIC that allows for precise modulation of brain circuits associated with individual OCD symptoms. The study aims to specify the ideal anatomical target for ALIC DBS for maximum therapeutic benefit in each patient.
Frequently Asked Questions
What is Connectomic Deep Brain Stimulation for Obsessive Compulsive Disorder?
Connectomic Deep Brain Stimulation for Obsessive Compulsive Disorder is a clinical trial registered under NCT05160129. Current status: RECRUITING.
What is the status of NCT05160129?
The current status of NCT05160129 (Connectomic Deep Brain Stimulation for Obsessive Compulsive Disorder) is: RECRUITING.
When did Connectomic Deep Brain Stimulation for Obsessive Compulsive Disorder start?
Connectomic Deep Brain Stimulation for Obsessive Compulsive Disorder started on 2021-08-13.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.